skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:058463/0187   Pages: 19
Recorded: 12/22/2021
Attorney Dkt #:1555472
Conveyance: SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 18
1
Patent #:
Issue Dt:
02/20/2018
Application #:
15616409
Filing Dt:
06/07/2017
Title:
INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
2
Patent #:
Issue Dt:
02/06/2018
Application #:
15676356
Filing Dt:
08/14/2017
Title:
INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
3
Patent #:
Issue Dt:
03/06/2018
Application #:
15676373
Filing Dt:
08/14/2017
Title:
INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
4
Patent #:
Issue Dt:
12/27/2022
Application #:
15712900
Filing Dt:
09/22/2017
Publication #:
Pub Dt:
03/28/2019
Title:
PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN AQUEOUS BLENDS OF WATER-MISCIBLE, PHARMACEUTICALLY ACCEPTABLE SOLVENTS
5
Patent #:
Issue Dt:
01/08/2019
Application #:
15848462
Filing Dt:
12/20/2017
Publication #:
Pub Dt:
12/13/2018
Title:
INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
6
Patent #:
Issue Dt:
10/23/2018
Application #:
15848505
Filing Dt:
12/20/2017
Title:
INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
7
Patent #:
Issue Dt:
03/09/2021
Application #:
16136804
Filing Dt:
09/20/2018
Publication #:
Pub Dt:
01/17/2019
Title:
INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
8
Patent #:
NONE
Issue Dt:
Application #:
16426492
Filing Dt:
05/30/2019
Publication #:
Pub Dt:
12/05/2019
Title:
Method and Formulation for Improving Roflumilast Skin Penetration Lag Time
9
Patent #:
NONE
Issue Dt:
Application #:
16563435
Filing Dt:
09/06/2019
Publication #:
Pub Dt:
05/21/2020
Title:
METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS
10
Patent #:
Issue Dt:
09/28/2021
Application #:
16778845
Filing Dt:
01/31/2020
Publication #:
Pub Dt:
05/28/2020
Title:
TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA HALF LIFE
11
Patent #:
Issue Dt:
10/24/2023
Application #:
17102056
Filing Dt:
11/23/2020
Publication #:
Pub Dt:
08/12/2021
Title:
INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST
12
Patent #:
NONE
Issue Dt:
Application #:
17155679
Filing Dt:
02/05/2021
Publication #:
Pub Dt:
06/03/2021
Title:
ROFLUMILAST FORMULATIONS WITH AN IMPROVED PHARMACOKINETIC PROFILE
13
Patent #:
Issue Dt:
05/28/2024
Application #:
17327236
Filing Dt:
05/21/2021
Publication #:
Pub Dt:
09/09/2021
Title:
METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS
14
Patent #:
Issue Dt:
06/11/2024
Application #:
17402051
Filing Dt:
08/13/2021
Publication #:
Pub Dt:
12/16/2021
Title:
TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA HALF LIFE
15
Patent #:
Issue Dt:
08/22/2023
Application #:
17443699
Filing Dt:
07/27/2021
Publication #:
Pub Dt:
02/03/2022
Title:
LAURETH-4 CONTAINING TOPICAL FORMULATIONS
16
Patent #:
NONE
Issue Dt:
Application #:
17513199
Filing Dt:
10/28/2021
Publication #:
Pub Dt:
05/05/2022
Title:
METHODS FOR TREATING VITILIGO LESIONS HAVING IMPROVED EFFICACY
17
Patent #:
NONE
Issue Dt:
Application #:
17527688
Filing Dt:
11/16/2021
Publication #:
Pub Dt:
05/19/2022
Title:
COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
18
Patent #:
Issue Dt:
04/18/2023
Application #:
17527856
Filing Dt:
11/16/2021
Publication #:
Pub Dt:
05/19/2022
Title:
COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
Assignor
1
Exec Dt:
12/22/2021
Assignee
1
500 PARK AVENUE, 3RD FLOOR
NEW YORK, NEW YORK 10022
Correspondence name and address
JOANNA MCCALL
1025 CONNECTICUT AVE NW, SUITE 712
COGENCY GLOBAL INC.
WASHINGTON, DC 20036

Search Results as of: 06/19/2024 11:40 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT